Curbstone Financial Management Corp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $726K | Buy |
5,750
+1,860
| +48% | +$245K | 0.12% | 146 |
|
|
2026
Q1 | $542K | Sell |
3,890
-50
| -1% | -$7K | 0.1% | 163 |
|
|
2025
Q4 | $484K | Hold |
3,940
| – | – | 0.09% | 175 |
|
|
2025
Q3 | $437K | Hold |
3,940
| – | – | 0.08% | 194 |
|
|
2025
Q2 | $437K | Sell |
3,940
-500
| -11% | -$53.2K | 0.09% | 183 |
|
|
2025
Q1 | $498K | Sell |
4,440
-1,200
| -21% | -$124K | 0.1% | 162 |
|
|
2024
Q4 | $521K | Hold |
5,640
| – | – | 0.11% | 161 |
|
|
2024
Q3 | $473K | Buy |
+5,640
| New | +$430K | 0.1% | 170 |
|
|
2024
Q2 | – | Sell |
-5,590
| Closed | -$409K | – | 198 |
|
|
2024
Q1 | $409K | Hold |
5,590
| – | – | 0.09% | 187 |
|
|
2023
Q4 | $453K | Sell |
5,590
-120
| -2% | -$9.34K | 0.1% | 174 |
|
|
2023
Q3 | $428K | Hold |
5,710
| – | – | 0.11% | 170 |
|
|
2023
Q2 | $440K | Hold |
5,710
| – | – | 0.1% | 171 |
|
|
2023
Q1 | $474K | Sell |
5,710
-200
| -3% | -$16.6K | 0.12% | 162 |
|
|
2022
Q4 | $507K | Buy |
+5,910
| New | +$468K | 0.13% | 155 |
|
|
2022
Q1 | – | Sell |
-6,040
| Closed | -$439K | – | 206 |
|
|
2021
Q4 | $439K | Buy |
6,040
+140
| +2% | +$9.64K | 0.08% | 194 |
|
|
2021
Q3 | $412K | Hold |
5,900
| – | – | 0.08% | 193 |
|
|
2021
Q2 | $406K | Sell |
5,900
-880
| -13% | -$58.8K | 0.08% | 193 |
|
|
2021
Q1 | $438K | Buy |
+6,780
| New | +$437K | 0.09% | 176 |
|
|
2019
Q3 | – | Sell |
-16,270
| Closed | -$1.1M | – | 174 |
|
|
2019
Q2 | $1.1M | Buy |
16,270
+650
| +4% | +$42.8K | 0.29% | 92 |
|
|
2019
Q1 | $1.01M | Sell |
15,620
-2,180
| -12% | -$145K | 0.28% | 97 |
|
|
2018
Q4 | $1.11M | Sell |
17,800
-3,150
| -15% | -$220K | 0.33% | 82 |
|
|
2018
Q3 | $1.62M | Sell |
20,950
-2,550
| -11% | -$193K | 0.42% | 66 |
|
|
2018
Q2 | $1.67M | Sell |
23,500
-500
| -2% | -$35.3K | 0.46% | 63 |
|
|
2018
Q1 | $1.81M | Buy |
24,000
+12,415
| +107% | +$987K | 0.51% | 56 |
|
|
2017
Q4 | $830K | Sell |
11,585
-16,585
| -59% | -$1.26M | 0.46% | 63 |
|
|
2017
Q3 | $2.28M | Buy |
28,170
+14,200
| +102% | +$1.09M | 0.66% | 46 |
|
|
2017
Q2 | $989K | Buy |
13,970
+1,450
| +12% | +$96.5K | 0.59% | 51 |
|
|
2017
Q1 | $850K | Buy |
12,520
+460
| +4% | +$32.3K | 0.52% | 60 |
|
|
2016
Q4 | $864K | Sell |
12,060
-14,740
| -55% | -$1.1M | 0.54% | 53 |
|
|
2016
Q3 | $2.12M | Buy |
26,800
+1,340
| +5% | +$109K | 0.68% | 41 |
|
|
2016
Q2 | $2.12M | Buy |
25,460
+640
| +3% | +$56.8K | 0.71% | 39 |
|
|
2016
Q1 | $2.28M | Buy |
24,820
+1,900
| +8% | +$171K | 0.77% | 33 |
|
|
2015
Q4 | $2.32M | Buy |
22,920
+11,080
| +94% | +$1.15M | 0.79% | 32 |
|
|
2015
Q3 | $1.16M | Buy |
11,840
+940
| +9% | +$104K | 0.84% | 30 |
|
|
2015
Q2 | $1.28M | Buy |
10,900
+2,075
| +24% | +$227K | 0.85% | 27 |
|
|
2015
Q1 | $866K | Buy |
8,825
+300
| +4% | +$30.5K | 0.58% | 48 |
|
|
2014
Q4 | $804K | Buy |
8,525
+2,315
| +37% | +$239K | 0.62% | 47 |
|
|
2014
Q3 | $661K | Sell |
6,210
-850
| -12% | -$83.2K | 0.52% | 57 |
|
|
2014
Q2 | $585K | Hold |
7,060
| – | – | 0.45% | 64 |
|
|
2014
Q1 | $500K | Buy |
+7,060
| New | +$554K | 0.41% | 69 |
|
Other funds holding GILD
Curbstone Financial Management Corp's GILD Position: Q2 2026 in Review
Curbstone Financial Management Corp increased its Gilead Sciences (GILD) stake by 48% in Q2 2026, buying an estimated $245K and bringing the position to 5,750 shares worth $726K. The position accounts for 0.12% of the portfolio, ranked #146.
Curbstone Financial Management Corp first reported a position in GILD in Q1 2014 and has held it in 40 quarters since. The position peaked at $2.32M in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Curbstone Financial Management Corp held 5,750 shares of Gilead Sciences worth $726K as of Q2 2026.
- Curbstone Financial Management Corp bought 1,860 Gilead Sciences shares in Q2 2026, an estimated $245K.
- Gilead Sciences made up 0.12% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #146 holding.
- Curbstone Financial Management Corp first reported a position in Gilead Sciences in Q1 2014 and has held it in 40 quarters since.
- Curbstone Financial Management Corp's Gilead Sciences position peaked at $2.32M in Q4 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.